CLDN3 and endometrium adenocarcinoma: In endometrial adenocarcinoma claudin-3 and -4 mRNA and protein increased with the clinicopathologic features of the tissue, progressing from simple to complex and from atypical hyperplasia to endometrioid carcinoma [33].